Welcome to the NICE Conference Call discussing Fourth Quarter 2024 Results, and thank you all for holding. All participants are at present in a listen-only mode. Following management’s formal ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Helen Knight, director of medicines evaluation at NICE This first-of-its-kind treatment works by reprogramming a patient's own immune cells to fight their cancer. Clinical trials have shown the ...
Helen Knight, director of medicines evaluation at NICE Current treatments often do not control seizures caused by LGS. The patient carer experts who gave evidence to the committee noted that the ...
After hours: March 14 at 7:48:04 PM EDT Loading Chart for NICE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results